All-digital interchip link IP enables instant compatibility for LTE basebands
SUNNYVALE, California — October 31, 2012 —Arteris Inc., the inventor and leading supplier of network-on-chip (NoC) interconnect IP solutions, today announced that Access Network Technology has selected Arteris® C2C™ chip-to-chip interconnect IP for systems-on-chip (SoCs) targeting smartphone application processors and LTE modems. Access Network Technology is the newly-formed joint venture created by Fujitsu Ltd, NTT Docomo, Inc. and NEC Corp. For more information about Access Network Technology, visit www.fujitsu.com/global/news/pr/archives/month/2012/20120801-01.html. To learn more about Arteris, visit www.arteris.com.
“We chose C2C because it is the de-facto all-digital interchip communication standard between mobile phone application processors and modems,” said Minoru Sakata, President of Access Network Technology. “Choosing the C2C chip to chip interconnect IP allows our products to be compatible with the existing ecosystem of C2C-enabled application processors and modems.”
“Arteris is excited to start our new relationship with Access Network Technology,” said K. Charles Janac, President and CEO of Arteris. “We are honored they have chosen us as a trusted IP provider and partner to help them serve the needs of the mobile communications equipment market.”
Arteris, Inc. provides Network-on-Chip interconnect IP and tools to accelerate System-on-Chip semiconductor (SoC) assembly for a wide range of applications. Results obtained by using the Arteris product line include lower power, higher performance, more efficient design reuse and faster development of ICs, SoCs and FPGAs.
Founded by networking experts and offering the first commercially available Network-on-Chip IP products, Arteris operates globally with headquarters in Sunnyvale, California and an engineering center in Paris, France. Arteris is a private company backed by a group of international investors including ARM Holdings, Crescendo Ventures, DoCoMo Capital, Qualcomm Incorporated, Synopsys, TVM Capital, and Ventech. More information can be found at www.arteris.com.